Johan Richter

Professor

Lund University

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (6)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Collaborators (5)

Per Ljungman

Karolinska University Hospital

SWEDEN

View details

Daniela Zackova

Head physician, consultant

University Hospital Brno

CZECH REPUBLIC

View details

Gustaf Edgren

Karolinska Institutet

SWEDEN

View details

Susanne Saußele

Ruprecht-Karls-Universität Heidelberg Medizinische Fakultät Mannheim

GERMANY

View details

Leif Stenke

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Johan Richter

Research Interests

Explore related searches

Contact this professor

Articles (6)

Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial

Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial

Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial

How to interpret the EURO-SKI study and its treatment-free remission outcome. Reply to R.P. Gale and J. Chen

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study

Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI

Collaborators (5)

Per Ljungman

Daniela Zackova

Gustaf Edgren

Susanne Saußele

Leif Stenke

Make your next move.